C32.1
Malignant neoplasm of supraglottis
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of aryepiglottic fold or interarytenoid fold, laryngeal aspect
- Malignant neoplasm of epiglottis (suprahyoid portion) NOS
- Malignant neoplasm of extrinsic larynx
- Malignant neoplasm of false vocal cord
- Malignant neoplasm of posterior (laryngeal) surface of epiglottis
- Malignant neoplasm of ventricular bands
Excludes Type 2
- malignant neoplasm of anterior surface of epiglottis (C10.1)
- malignant neoplasm of aryepiglottic fold or interarytenoid fold, hypopharyngeal aspect (C13.1)
- malignant neoplasm of aryepiglottic fold or interarytenoid fold, marginal zone (C13.1)
- malignant neoplasm of aryepiglottic fold or interarytenoid fold NOS (C13.1)
Medical Intelligence & Overview
Malignant neoplasm of the supraglottis, classified under ICD-10 code C32.1, refers to cancerous growths located in the upper part of the larynx above the vocal cords. The supraglottis includes various structures such as the aryepiglottic folds, the epiglottis, false vocal cords, and the ventricular bands. This type of cancer can affect speech, breathing, and swallowing, highlighting the importance of early detection and management.
Causes & Symptoms
Clinical Causes: Long-term smoking Heavy alcohol consumption Exposure to certain environmental pollutants and toxins Chronic irritation or inflammation of the laryngeal tissues Human papillomavirus (HPV) infection Genetic predisposition
Key Symptoms: Persistent sore throat Hoarseness or changes in voice that last for more than two weeks Difficulty swallowing or a sensation of something stuck in the throat Chronic cough or cough with blood Lump or mass felt in the neck or throat Unexplained weight loss Breathing difficulties or noisy breathing
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination and investigative procedures. An otolaryngologist may perform a physical neck examination to feel for lumps or swelling. Further assessments include: - Endoscopic examination of the larynx - Biopsy of suspicious tissue for histopathological analysis - Imaging studies such as CT scan or MRI to determine the extent of the tumor - PET scan may assist in detecting metastasis or spread Precise diagnosis helps determine the stage of cancer and guides treatment planning.
Treatment Protocols: Treatment options for malignant neoplasm of the supraglottis focus on removing or destroying cancerous tissue and preserving vital functions. Approaches include: - Surgical removal of the tumor, which may involve partial or total laryngectomy depending on tumor size and location - Radiation therapy to destroy cancer cells or shrink tumors - Chemotherapy, often combined with radiation therapy, especially in advanced stages - Targeted therapy and immunotherapy are emerging options for specific cases Rehabilitation post-treatment, such as speech therapy, may be necessary to aid in communication and swallowing. Multidisciplinary care ensures comprehensive management of the condition.
Clinical Advice & FAQs
Billing Guidance
Is C32.1 a billable ICD-10 code?
Yes, C32.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C32.1?
Clinical documentation must specify the nature of Malignant neoplasm of supraglottis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
